• Home
  • News
    • Politics & Government
    • Business & Economy
    • Crime / Courts
    • Health / Medicine
  • Sports
    • High School Sports
    • Radio Iowa Poll
  • Affiliates
    • Affiliate Support Page
  • Contact Us
    • Reporters

Radio Iowa

Iowa's Radio News Network

You are here: Home / Health / Medicine / Omaha medical center testing third COVID-19 vaccine

Omaha medical center testing third COVID-19 vaccine

January 6, 2021 By Matt Kelley

Diana Florescu

While select groups of Iowans are now getting COVID-19 vaccines developed by either Pfizer or Moderna, a third company’s vaccine is now going into the third phase of testing in Omaha/Council Bluffs.

Dr. Diana Florescu, an infectious diseases specialist at the University of Nebraska Medical Center, says they’re grateful and excited to be chosen as a site for this important work. Dr. Florescu says, “Our hope is that this vaccine will prevent people from developing severe disease and decrease the chances of being hospitalized or dying.”

The investigational vaccine was developed by Novavax, a biotechnology company headquartered in Maryland. The Omaha-based hospital plans to enroll up to one-thousand study participants from Nebraska and Iowa.

“We encourage individuals who won’t be receiving the Pfizer or Moderna vaccines in the next three to six months to consider enrolling in the clinical trial,” Florescu says. “Participants in the Novavax vaccine clinical trial can still receive the Pfizer or Moderna vaccines when it is available to them and still remain in the trial.”

The Novavax vaccine is protein-based and an added component is designed to boost a person’s immune response to stimulate higher levels of antibodies. “Like everyone else, we want to beat this pandemic. To do so, we need multiple, safe and effective COVID-19 vaccines,” Florescu says. “We also want to involve the most vulnerable communities: minorities, people over the age of 65, and those with other health conditions.”

The vaccine does not contain live or inactivated virus, she says, so it does not cause infection. It requires two shots to be given three weeks apart.

For more information, visit: unmc.edu/covidvaccinetrial

Share this:

  • Facebook
  • Twitter

Filed Under: Health / Medicine, News Tagged With: Coronavirus

Featured Stories

Jury returns guilty verdict in shooting death of State Trooper

Summit has easements for 20% of carbon pipeline route through Iowa

Morel mushroom hunters on hold without warmer conditions

Trinity Health aquiring all MercyOne health properties

Field of Dreams site developer wants to bid on state baseball, softball tournaments

TwitterFacebook
Tweets by RadioIowa

Radio Iowa/Baseball Coaches Association High School Poll 5/16/22

Iowa assistant coach Kirk Speraw to retire

Northern Iowa prepares for Missouri Valley Conference softball tournament

T.J. Otzelberger announces staff changes at Iowa State

Iowa State adds transfer guard

More Sports

eNews and Updates

Enter your email address:

Delivered by FeedBurner

Archives

Copyright © 2022 · Learfield News & Ag, LLC